All relevant data are within the paper and are also available from <http://www.griv.org/functSNPs/>.

Introduction {#sec004}
============

More than fifteen genome-wide association studies (GWAS) have been conducted on AIDS since the seminal GWAS on HIV-1 progression in 2007 \[[@pone.0136989.ref001],[@pone.0136989.ref002]\]. They mainly revealed associations in the region of the chromosome 6 *HLA* loci \[[@pone.0136989.ref001],[@pone.0136989.ref003],[@pone.0136989.ref004]\], in particular a single nucleotide polymorphism (SNP) in the *HCP5* gene, rs2395029. This SNP is in complete linkage disequilibrium with the *HLA-B5701* allele, already identified by several candidate-gene studies for its role in non-progression and the control of viral load \[[@pone.0136989.ref005]--[@pone.0136989.ref007]\]. Candidate gene studies also contributed to the discovery of another important polymorphisms, *CCR5-Δ32* \[[@pone.0136989.ref008]--[@pone.0136989.ref010]\].

Most of the genetic association studies on AIDS have relied on endpoints such as viral load at setpoint or time to reach a clinical symptom (e.g. CDC AIDS 1993 or death). The Genetics of Resistance to Immunodeficiency Virus (GRIV) cohort, composed of extreme phenotypes, non-progressors \[[@pone.0136989.ref011]--[@pone.0136989.ref013]\] and rapid progressors \[[@pone.0136989.ref014]\], is different since it relies on a case-control analysis.

For many human traits and diseases including AIDS, a substantial portion of heritability remains unexplained \[[@pone.0136989.ref015],[@pone.0136989.ref016]\]. Strategies to increase the number of novel findings are being developed, including rare variants, facilitated by sequencing, or meta-analyses but with limited success to date \[[@pone.0136989.ref017]\].

Another approach that has received considerable attention is the use of pathway-based association tests that aim to look for an enrichment of associations in sets of genes within the same biological pathway \[[@pone.0136989.ref018]--[@pone.0136989.ref020]\]. Genetic association studies on AIDS have been described for specific pathways \[[@pone.0136989.ref021]\], but a systematic pathway analysis has yet to be performed. Increasingly popular, expression quantitative trait loci (eQTLs) quantify the relationship between genetic polymorphisms and gene transcription \[[@pone.0136989.ref022],[@pone.0136989.ref023]\]. It has been proposed that eQTL are of the utmost important in the development of pathological traits \[[@pone.0136989.ref024],[@pone.0136989.ref025]\].

In the present work, we have developed a novel, general-purpose pipeline based on the use of several eQTL databases as filters to preselect so-called functional SNPs. We used the databases "GHS_Express" by \[[@pone.0136989.ref026]\], "Gene Expression Analysis Based on Imputed Genotype" by \[[@pone.0136989.ref027]\], and "Genevar" by the Sanger Institute \[[@pone.0136989.ref028]--[@pone.0136989.ref030]\]. These databases correlate each SNP with gene expression in a specific cell line. We preselected the SNPs exhibiting the most significant *p*-values in each database, and to further warrant a prominent functional impact on gene expression, we selected the ones concurrently found in two or three databases. This restricted set of candidate functional SNPs was tested for genetic associations with AIDS using the GRIV cohort of extreme progression to AIDS \[[@pone.0136989.ref004],[@pone.0136989.ref011]--[@pone.0136989.ref014]\] and using the Amsterdam Cohort Studies (ACS) cohort for replication \[[@pone.0136989.ref031]\]. As an added benefit, the eQTL databases allow us to directly associate gene expression levels with AIDS progression.

This unique approach selects a few hundred candidate SNPs to be tested for genetic association with AIDS, on the sole basis of their functional impact on gene expression, and it also differs from past candidate gene studies \[[@pone.0136989.ref032]\] since there was no gene pre-selection based on specific knowledge of AIDS biology. In this article, we describe how this approach was successful in unravelling novel, statistically-significant associations with biological activities particularly relevant to HIV-1 infection.

Results {#sec005}
=======

[Fig 1](#pone.0136989.g001){ref-type="fig"} shows a schematic overview of how we integrated eQTL data and progression towards AIDS in two cohorts to draw new genetic associations.

![Schematic summary of our methodology.\
The data from three databases are integrated to provide us with functional SNPs likely to be associated with changes in gene transcription in the tissue of interest. Using the SNAP Pairwise LD server, we only kept independent SNPs by removing superfluous SNPs that were in linkage disequilibrium (*r* ^2^ ≥ 0.2). Among those SNPs, associations with slow and non-progression towards AIDS are sought and replicated. Randomisations are carried out in order to evaluate the statistical robustness of our results. Finally, the genetic associations are used to link progression to AIDS and gene expression in candidate genes.](pone.0136989.g001){#pone.0136989.g001}

Functional SNPs {#sec006}
---------------

We determined the modes of the associations between SNPs and gene transcription levels as described in the Methods section and found: 16,000 additive associations, 2173 recessive associations, 2050 dominant associations, 1133 overdominant associations, 3491 additive-or-dominant associations and 682 additive-or-recessive associations. Ambiguous modes were considered dominant for the remainder of the study, given the overwhelming majority of associations is additive.

Using the threshold *p* = 10^−4^ and the additive mode for eQTLs, we obtained a set of 1788 SNP/gene pairs corresponding to 1706 distinct SNPs and 567 distinct genes. The set of SNP/gene pairs is made of 73 pairs common to all three databases, 33 pairs common to Cambien and Genevar only, 527 pairs common to Dixon and Genevar only and 1155 pairs common to Cambien and Dixon only.

Linkage disequilibrium between those SNPs was removed. Pairs of SNPs with more than *r* ^2^ ≥ 0.2 were identified using the Broad Institute's 'SNAP Pairwise LD'. (See [S2 File](#pone.0136989.s002){ref-type="supplementary-material"} for details).

Such pairs define a 'linkage disequilibirum graph', where SNPs are vertices and edges connect SNPs in linkage disequilibrium. The connected components of this graph are calculated and a representative SNP is chosen for each connected component (for convenience's sake, we chose the SNP with the lowest ID in dbSNP). Generally, though not always, consistent groups of genes are regulated among the SNPs within a connected component. We obtain a set of 655 independent SNPs (see [S1 Table](#pone.0136989.s003){ref-type="supplementary-material"}).

Genetic associations with AIDS progression {#sec007}
------------------------------------------

Of the 655 SNPs selected above, *N* = 654 could be imputed in GRIV and ACS cohorts and their association with slow progression or non-progression to AIDS could be sought in GRIV and replicated in ACS as described in the Methods section. Given that there was a small number of SNPs to be tested and that we resorted to replication, a *p*-value of *α* = 0.05 was used both for the association in the GRIV cohort and for the replication in the ACS cohort. With this choice, a low type-I error was expected.

Genetic associations {#sec008}
--------------------

Nine out of the 654 SNPs are associated with slow and non-progression towards AIDS (see [Table 1](#pone.0136989.t001){ref-type="table"} and [S1 File](#pone.0136989.s001){ref-type="supplementary-material"} for the Q-Q plots). Which is more than the number of associations expected by chance. We recalculated all the *r* ^2^ values for the associations on chromosome 6 in the DESIR cohort. All associations are at linkage equilibrium but one pair: rs3130350/rs3749971 (*r* ^2^ = 0.6, distance 985 kbp). These SNPs were not reported by the SNAP Pairwise LD server because they are more than 500 kbp apart. The final number of independent associations is 8.

10.1371/journal.pone.0136989.t001

###### List of the significant associations (*p* ≤ 0.05) with slow and non-progression.

Alleles, allele frequencies (AF), positional data and genetic modes are provided with the results of the statistical inferences. Opposite signs for the β coefficients are required for an association to be replicated in the GRIV (non-progression) and ACS cohorts (time to AIDS93).

![](pone.0136989.t001){#pone.0136989.t001g}

  SNP                                                 Alleles Ref/Alt   AF (Alt)   Chromosome/position   Mode   *β* (GRIV)    *p* (GRIV)   *β* (ACS)   *p* (ACS)   Allele associated with non-progression                 
  --------------------------------------------------- ----------------- ---------- --------------------- ------ ------------- ------------ ----------- ----------- ---------------------------------------- ------------- ---
  **732563**                                          T                 C          53%                   8      23,488,013    additive     -0.23       0.029       0.21                                     0.029         T
  **732563**                                          T                 C          53%                   8      23,488,013    recessive    -0.41       0.024       0.40                                     0.007         T
  **2205418**                                         T                 C          12%                   21     28,657,885    recessive    -2.24       0.038       2.81                                     1.5·10^--4^   T
  **2241335**                                         C                 T          45%                   7      134,294,616   dominant     0.44        0.015       -0.34                                    0.034         T
  **2242229**                                         G                 T          78%                   17     75,246,420    recessive    0.49        0.003       -0.33                                    0.025         T
  **2921446**                                         C                 A          66%                   10     72,691,727    dominant     0.53        0.037       -0.48                                    0.024         A
  **3130350**                                         G                 T          7%                    6      30,360,062    additive     -0.66       0.019       0.51                                     0.001         G
  **3130350**                                         G                 T          7%                    6      30,360,062    dominant     -0.73       0.015       0.42                                     0.010         G
  **3130501**                                         A                 G          77%                   6      31,168,676    dominant     -0.78       0.021       0.81                                     0.038         A
  **3749971** [\*](#t001fn001){ref-type="table-fn"}   G                 A          6%                    6      29,374,998    dominant     -0.67       0.036       0.37                                     0.031         G
  **4714580**                                         A                 G          83%                   6      42,206,820    recessive    -0.32       0.049       0.33                                     0.045         A

(\*) Note that rs3749971 is in linkage disequilibrium with rs3130350 and is therefore not considered an independent finding in our statistics (see text).

Statistical significance: estimation of the sensitivity {#sec009}
-------------------------------------------------------

To demonstrate that the number of significant hits really arises from associations between polymorphisms and the phenotypes, we carried out two sets of randomisations: (1) phenotype randomisation to show that the choice of the functional SNPs is itself not sufficient to warrant significant hits, (2) SNP randomisation to show that neither is the spectrum of phenotypes is. Those randomisations come with the added benefit that we can estimate the false discovery rate and its distribution (hence, of the sensitivity of our method). We carried out 1000 phenotype randomisations and 36 SNP randomisations (12 of which are sampled from the eQTL databases). The results are shown in [Fig 2](#pone.0136989.g002){ref-type="fig"}.

![Statistical significance of our associations.\
Histogram of the number of SNPs that pass the significance criterion for this study using phenotype and SNP randomisations. These results provide us with a way to estimate the sensitivity of our study (diamond): it would be extremely unlikely for our eight independent findings to arise by chance alone (*p* = 0.001).](pone.0136989.g002){#pone.0136989.g002}

The phenotype randomisations allow us to estimate two useful, complementary measures from the distribution: the fraction of expected false positives ('sensitivity') and the likelihood of obtaining as many independent SNPs as we did or more by chance alone (*p*-value). The sensitivity (true positives) is estimated at 75% (in other words 25% false discovery rate) with a 95% credible interval of 38% to 100%. Under the null hypothesis, the probability of obtaining as many independent SNPs as we did or more is *p* = 0.001.

Although their number is far lower than that of phenotype randomisations (due to technical reasons, see [Materials and Methods](#sec013){ref-type="sec"}), SNP randomisations give results that are well aligned with phenotype randomisations: the location and spread of the distributions cannot be distinguished.

Regulated genes and biological significance {#sec010}
-------------------------------------------

We mapped the 8 SNPs back to the corresponding genes of the SNP/gene pairs identified earlier and the direction of the correlation with each gene's expression. This allowed us to associate gene expression with slow or non-progression to AIDS. The expression of the following genes therefore could be important in progression towards AIDS: *CCT8*, *DNAJB12*, *ENTPD4*, *GUCA1B*, *HCG27*, *MRPS7*, *MRPS10*, *SLC35B4* and *ZFP57*. No additional gene was identified by considering the connected components of the LD graph. The results are presented in [Table 2](#pone.0136989.t002){ref-type="table"}.

10.1371/journal.pone.0136989.t002

###### List of SNP/gene pairs associated with AIDS progression.

The genetic association is linked back to its association with gene expression levels to provide an association between transcription levels (we use the word 'regulation' for convenience's sake) and AIDS progression.

![](pone.0136989.t002){#pone.0136989.t002g}

  SNP                   Chromosome   Gene        Gene function                                                                          Association with non-progression
  --------------------- ------------ ----------- -------------------------------------------------------------------------------------- ----------------------------------
  **732563**            8            *ENTPD4*    ectonucleoside triphosphate diphosphohydrolase 4                                       Down-regulation
  **2205418**           21           *CCT8*      chaperonin containing TCP1, subunit 8 (theta)                                          Down-regulation
  **2241335**           7            *SLC35B4*   solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4   Up-regulation
  **2242229**           17           *MRPS7*     mitochondrial ribosomal protein S7                                                     Up-regulation
  **2921446**           10           *DNAJB12*   DnaJ (Hsp40) homolog, subfamily B, member 12                                           Down-regulation
  **3749971/3130350**   6            *ZFP57*     ZFP57 zinc finger protein                                                              Down-regulation
  **3130501**           6            *HCG27*     HLA complex group 27 (non-protein coding)                                              Down-regulation
  **4714580**           6            *GUCA1B*    guanylate cyclase activator 1B (retina)                                                Down-regulation
  **4714580**           *6*          *MRPS10*    mitochondrial ribosomal protein S10                                                    Down-regulation

(\*) Note that rs3749971 is in linkage disequilibrium with rs3130350 and is therefore not considered an independent finding (see text).

The *ENTPD4* gene codes for a protein involved in the metabolism of purines and pyrimidines. Our results suggest that down-regulation of *ENTPD4* is associated with a slower progression to AIDS. It is known that CD39, a member of the ENTPD family, is the dominant immune system ectonucleotidase that hydrolyses extracellular ATP and ADP into AMP at the sites of immune activation. A previous study indicated that a down-regulated *CD39* expression in CD4 T cells was associated with a slower progression to AIDS \[[@pone.0136989.ref021],[@pone.0136989.ref033]\]. Interestingly, the *ENTPD4* gene is among the genes significantly up-regulated (6-fold up-regulation) during antigen presentation in CD4 T cells by the presence of HIV's gp120/V3 peptides \[[@pone.0136989.ref034]\]. *ENTPD4* is also expressed in B lymphocytes \[[@pone.0136989.ref035]\] and GTEx data support a weak association between rs2241335 and rs2241336 polymorphism and *ENTPD4* expression levels (*p* = 0.1, *N* = 42) in the cell line of EBV-transformed lymphocytes \[[@pone.0136989.ref022]\].

Interestingly, two nuclear genes coding for mitochondrial ribosomal proteins were found in our study (*MRPS7* on chromosome 17 and *MRPS10* on chromosome 6). Somewhat surprisingly, a *lower* transcription of *MRPS10* but a *higher* transcription of *MRPS7* are associated with slow and non-progression towards AIDS. Although the involvement in AIDS progression of those genes has never been reported, the implication of mitochondria in AIDS pathogenesis has been suggested by several studies in the past. For example, genetic associations between mitochondrial haplotypes and AIDS progression have been reported \[[@pone.0136989.ref036],[@pone.0136989.ref037]\]. *MRPS12* was also among 185 genes predictive of HIV-1 resistance and 29 infection information exchanger genes \[[@pone.0136989.ref038]\]; as a consequence, Huang and colleagues speculated that *MRPS12* could be important for the coordination of HIV infection. Furthermore, gene set analyses have suggested that mitochondria could be key in the immune response against HIV infections even though the exact pathways (energy metabolism, cell apoptosis or cell cycle dysregulation) are yet to be identified \[[@pone.0136989.ref039]\]. MRPS10 interacts with a number of proteins involved in HIV aetiology (see [S1 File](#pone.0136989.s001){ref-type="supplementary-material"}). An association between *MRPS7*'s expression and rs2242229 is also reported in the Geuvadis database (*p* = 3.4×10^−23^) \[[@pone.0136989.ref023]\].

The identification of *DNAJB12* as a potentially important gene is reminiscent of the observation that the HSP40/DNAJ family proteins play a role in infection of various viruses. Urano and colleagues identified DNAJ/HSP40B6 as a potential regulator of HIV-1 replication \[[@pone.0136989.ref040]\]. It is an interesting finding considering the attention that another chaperone, namely HSP90, has recently attracted: HSP90 could promote infectiousness of HIV by controlling HIV reactivation from latency \[[@pone.0136989.ref041]\] and several inhibitors of HSP90 are currently in clinical development \[[@pone.0136989.ref042]\]. This is consistent with our observation that a lower expression of *DNAJB12*, which is part of the HSP90 pathway \[[@pone.0136989.ref043]\], correlates with slow or non-progression towards AIDS. DNAJB12 also interacts with many proteins known to be associated with HIV infection: among the twelve protein-protein interactions reported by InnateDB \[[@pone.0136989.ref044]\], eight proteins (DSTN, EGFR, HSPA8, MME, MYC, SGTA and UBC) are also found in the HIV-1 Human Interaction Database \[[@pone.0136989.ref045]\] (see [S1 File](#pone.0136989.s001){ref-type="supplementary-material"}). The association of low expression of chaperone-coding gene *CCT8* with slow- and non-progression also points to a role of chaperones in promoting HIV infection; also of interest is the observation that CCT8 is one of the proteins to be differentially regulated in synaptosomal isolates from HIV/gp120 transgenic mice \[[@pone.0136989.ref046]\]; an association between *CCT8*'s expression and rs2205418 is also reported in the Geuvadis database (*p* = 1.7×10^−8^) \[[@pone.0136989.ref023]\].

*ZFP57* is a transcriptional regulator involved in DNA methylation and genomic imprinting during development but its gene expression also occurs at in adult peripheral blood cells \[[@pone.0136989.ref047]\]. A lower transcription correlates with slow or non-progression towards AIDS. As reported by Plant et al., SNPs associated with differential transcription of this gene have already been highlighted as associated with AIDS progression \[[@pone.0136989.ref004],[@pone.0136989.ref047],[@pone.0136989.ref048]\]. The impact of ZFP57 could be due to the promotion of viral latency through hypermethylation \[[@pone.0136989.ref047]\] or through its interaction with TRIM28, which was shown to enhance HIV infections in model cell lines \[[@pone.0136989.ref049]\].

The gene *HCG27* (HLA complex group 27) is a non-protein coding gene; though *HLA* genes have been consistently been associated with AIDS progression \[[@pone.0136989.ref002],[@pone.0136989.ref050]\], the role of this gene (as well as that of other candidate genes revealed in this study, such as *SLC35B4*, *GUCA1B*) is difficult to evaluate to the best of our knowledge. Note that *GUCA1B* could be a passenger finding: indeed, it is the second of two genes whose expression correlates with the rs4714580 polymorphism, the first being *MRPS10*, which might be the causal gene.

Associations with rapid progression towards AIDS {#sec011}
------------------------------------------------

Genetic associations with rapid progression towards AIDS were sought among the list of 654 functional SNPs. Our randomisation tests demonstrated that the associations were not statistically significant (see [S1 File](#pone.0136989.s001){ref-type="supplementary-material"}). This demonstrates that these randomisation procedures act as effective safeguards against spurious associations.

Discussion {#sec012}
==========

Genomewide association studies have successfully allowed the confident discovery of many factors involved in human diseases. However, they haven't yet told the whole story. In AIDS, they have mostly yielded associations in the *HLA* region and in relation with the *CCR5* region \[[@pone.0136989.ref012]\]. Still, there obviously is a gap between our current ability to detect genetic associations and our capacity to predict the risk based on genetics alone; the 'missing heritability' hints that there remain difficult-to-identify genetic markers \[[@pone.0136989.ref015],[@pone.0136989.ref051]\]. Larger cohorts are used to overcome this \[[@pone.0136989.ref017]\] but another route consists in integrating data from various sources. This study provides a successful implementation of the second solution.

The rationale behind our work is that the integration of eQTL data provides us with a reliable SNP/gene map, not without similarities with the concept of 'eSNP' (genetic variants directly associated with higher or lower transcript expression levels), which is more likely to point towards functional and causal factors. Using three gene expression databases (GHS_Express, Gene Expression Analysis Based on Imputed Genotype and Genevar), we could identify polymorphisms more likely to play a functional role. Our approach is substantiated by the number of SNP/gene pairs confirmed in the GTEx and Geuvadis DBs. The randomisations involving SNPs sampled from the eQTL databases highlight the value of integrating data from several databases.

We looked for genetic associations in GRIV and replicated those in ACS and found eight independent SNPs significantly associated with slow or non-progression to AIDS. An important facet of this study was the evaluation of the statistical robustness of our findings, which confidently supports a significant of positive associations.

eQTL databases were not only essential in the preparation of a carefully-selected set of functional SNPs, they also were instrumental in identifying candidate genes whose expression profiles could be more directly associated with the AIDS progression phenotypes: *ENTPD4*, *CCT8*, *SLC35B4*, *MRPS7*, *MRPS10*, *DNAJB12*, *ZFP57*, *HCG27* and *GUCA1B*. Overall, we have found in the existing literature and in published datasets compelling biological grounds for the possible implication of the genes identified in this study in progression to AIDS. Interestingly, for six out of those eight genes, down-regulation is associated with non-progression, which makes them appealing targets to combat HIV infections. Importantly, our study revealed a number of yet uninvestigated candidate genes, which can further our understanding of AIDS infection and AIDS progression as well as facilitate the discovery of new drugs.

Researchers working on other diseases could easily apply this method to their own genome-wide datasets. The set of 655 functional SNPs is provided as [S1 Table](#pone.0136989.s003){ref-type="supplementary-material"} and is available from <http://www.griv.org/functSNPs/>.

Materials and Methods {#sec013}
=====================

Sets of functional SNPs {#sec014}
-----------------------

In this work, we investigated associations between gene expression and AIDS progression. The associations were sought through the selection of 'functional SNPs', known to be associated with changes in gene transcription levels; informally, we can define a functional SNP as a SNP likely to have a direct biological action through gene expression. We achieved this by integrating the data obtained from three separate mRNA-expression databases: GHS_Expression (hereafter referred to as the 'Cambien' database) \[[@pone.0136989.ref026]\], Gene Expression Analysis Based on Imputed Genotype (hereafter referred to as the 'Dixon database) \[[@pone.0136989.ref027]\] and Genevar \[[@pone.0136989.ref028]--[@pone.0136989.ref030]\]. (See [S2 File](#pone.0136989.s002){ref-type="supplementary-material"} for details).

### Data integration {#sec015}

Formally, a SNP *s* is considered functional if it meets the following criterion: there exists a gene *g* such that the genotype of *s* consistently and significantly (reported *p*-value is less than 10^−4^) correlates with the transcription levels of the gene *g* in at least two of the three databases Cambien, Dixon and Genevar. This selection warrants high confidence in the selection. The mode (additive) must be coherent throughout the datasets and the correlation must be consistent including across different probes within a single dataset. The set of functional SNPs is a list of elements ({*S*, *s*}, *g*, *m*, *d*, *D*), where {*S*, *s*} is a biallelic SNP (defined as a major/minor pair of alleles), *g* is a gene, *m* is the mode in which the allele *s* is associated with an altered expression of the gene *g*, *d* is the direction of regulation (+ or-) and *D* the datasets where the regulation is observed (Cambien, Dixon or Genevar).

The threshold *p* \< 10^−4^ was partly constrained by the fact that the Cambien database only reports associations for which the *p*-value is less than 10^−4^ already. Had the data been complete, other choices of threshold could have been made, provided the significance of the results could be ascertained using the randomisations described below.

Cohorts {#sec016}
-------

### The Genomics of Resistance to Immunodeficiency Virus Cohort (GRIV) and the French control group {#sec017}

The GRIV cohort, established in 1995 in France, is a collection of DNA samples used to identify host genes associated with slow progression and with rapid progression to AIDS \[[@pone.0136989.ref007],[@pone.0136989.ref010],[@pone.0136989.ref052]\]. The study was reviewed and approved by the institutional review board of Hôpital Saint-Louis (Paris, France) before the study began. All participants provided written informed consent. Only white individuals of European descent living in France were eligible for enrolment to reduce confounding effects by population substructure. These criteria limit the influence of the ethnic and environmental factors (all subjects live in a similar environment and are infected by HIV-1 subtype B strains) and put an emphasis on the genetic make-up of each individual in determination of long term non-progression (NP) to AIDS. The NP group (*n* = 270) was composed of 200 males and 70 females aged at inclusion from 19 to 62 (mean age 35). We used the Data from an Epidemiological Study on Insulin Resistance Syndrome (DESIR) program as a control group. (See [S2 File](#pone.0136989.s002){ref-type="supplementary-material"} for details).

### The Amsterdam Cohort Studies Cohort (ACS) {#sec018}

The ACS cohort was composed of 316 HIV-1 homosexual men. The study was reviewed and approved by the AMC Medical Ethics Committee. All participants provided written informed consent. This cohort was established to follow the course of HIV-1 infection using various endpoints related to HIV-1 infection and AIDS \[[@pone.0136989.ref031],[@pone.0136989.ref053]\].

Processing genomic data {#sec019}
-----------------------

We excluded individuals who were related and outliers based on population stratification. SNPs were excluded when, within the control group, they were out of Hardy-Weinberg equilibrium, when the minor allelic frequency was less than 1% or when missing data were greater than 2%. Individuals with more than 5% missing data or with high heterozygosity were excluded.

In order to identify all the known SNPs in LD with our selected list of SNPs, present in the HapMap database, we imputed all SNPs in the GRIV, ACS and control subjects using the 1000 Genomes phase I data \[[@pone.0136989.ref054]\]. Only the SNPs reliably imputed were retained.

The SNPs associated with non-progression towards AIDS were sought in the GRIV cohort and then replicated in ACS. In order to be replicated an association must be consistent in terms of its genetic mode and effect direction.

For each functional SNP, we computed the *p*-values of the association in the GRIV cohort either with non-progression or with rapid progression using a standard case-control analysis (non-progression vs control and rapid progression vs control). All modes (dominant, recessive, and additive) were tested. Sex and the first two stratification axes were included as covariates. The significance threshold for an association with progression was set at *α* = 0.05.

For each functional SNP, we computed the *p*-values of the association in the ACS cohort with progression using the (censored) variable 'time to AIDS 1993 after HIV-1 infection' \[[@pone.0136989.ref010]\]. The first two stratification axes were included as covariates (sex was not included as all subjects are male). (See [S2 File](#pone.0136989.s002){ref-type="supplementary-material"} for details).

Randomisation tests {#sec020}
-------------------

Though the method described in this paper used expression data to investigate associations between gene regulation and phenotypes, we assessed the significance of our findings at the SNPs' level. Indeed, there currently does not exist a method to randomise expression data alongside genotypes. Therefore, the significance really tests the usability and robustness of the concept of 'functional SNP' we have used in this study. The significance of our findings was testing using two randomisation procedures: phenotype randomisation and SNP randomisation.

### Phenotype randomisation {#sec021}

In GRIV, the NP and control phenotypes were randomised using GNU R's *sample* function. In ACS, the 'time to AIDS 1993' variable was similarly randomised using GNU R's *sample* function; the corresponding censored status was carried along during randomisation.

### SNP randomisation {#sec022}

In order to avoid any bias, 36 sets of SNPs comparable to the set of functional SNPs described above were selected for the SNP randomisation. SNP sets had to be comparable in terms of allele frequency, genotyping/imputation ratio, linkage disequilibrium, and distance to nearest gene. Other factors (sex, stratification principal components, outcome) were maintained unaltered. Only 36 sets were produced: (1) given the constraints, the number of sets is limited by nature, (2) SNP randomisation is computationally expensive than phenotype randomisation, (3) the distribution resulting from SNP randomisation is used to corroborate the distribution obtained using more extensive phenotype randomisation. (See [S2 File](#pone.0136989.s002){ref-type="supplementary-material"} for details).

Supporting Information {#sec023}
======================

###### Supporting Results.

Which eQTL database can the functional SNPs traced back to? Q-Q plots for the analyses. Negative results for rapid progression. Interactions between the identified genes and AIDS/HIV.

(PDF)

###### 

Click here for additional data file.

###### Supporting Methods.

Mode in the Cambien dataset. Additional details about the cohorts. Workflow for preprocessing genomic data and testing the association with slow or non-progression. Parameters for linkage disequilibrium. Details about the SNP randomisation.

(PDF)

###### 

Click here for additional data file.

###### List of functional SNPs.

List of SNPs which with consistent behaviour in the three eQTL databases used in this work.

(XLSX)

###### 

Click here for additional data file.
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